BIT's 8th Annual World Protein & Peptide Conference
★ Submission Guideline

1. The organizers of PepCon-2015 welcome all abstracts within the scope of the meeting. Submitted abstracts will be reviewed by experts and be scheduled for either oral or poster presentation during the congress if the topic is relevant and the quality of the data justifies scheduling. Irrelevant or poor-quality abstracts may be rejected.


2. Abstracts shall be submitted to our coordinators by email: sally@bit-pepcon.com.


3. Abstracts need to written in clear English, taking into account the specifications below (see also sample on the next page):

  1. Maximum word count of abstract title: 20 words.


  2. Maximum word count of abstract text: 350 words (adjust in case of tables/figures).


  3. Abstract topic should be selected during the online submission process from the list of predefined topics to facilitate abstract review and scheduling.


  4. A minimum of three specific keywords should be added during online submission for indexing of the abstract. Specific keywords are: name(s) of drug(s) investigated, molecular target molecule(s), disease(s) studied, biochemical or biological function(s) studied. Avoid the use of vague keywords, such as: angiogenesis, cell death, cancer, tumor, drug development, drug therapy. The Organizing Committee of PepCon-2014 reserves the rights to delete, edit, or add keywords to achieve uniformity throughout abstract publications.


  5. Use International Nonproprietary Names (INN) or research codes to identify drugs throughout the abstract. Proprietary names may be used in the abstract text, not the abstract title. The first time the drug is mentioned use the INN and put proprietary names between brackets.


  6. The identity of a new, previously unpublished drug substance should be disclosed in the abstract, either by providing its structural formula or its full chemical name

4. Abstracts will be published exactly as submitted. No editing of abstract texts will be done. However, non-adherence to the above guidelines may be corrected (e.g. use of drug names, keywords) by the meeting organizers.


5. After submission abstracts can no longer be changed by the authors. Should minor changes be necessary after submission, the author should notify Ms. Sally Ma at sally@bit-pepcon.com describing exactly the nature of the change to be made. The PepCon-2015 organizers will then implement the change. If major changes are required the author should submit a revised abstract as an entirely new abstract and send a request to sally@bit-pepcon.com to delete the original abstract. The addition of a co-author constitutes a major change.


6. After completion of the abstract review, the submitting author will receive scheduling information via email. Abstracts cannot be withdrawn after receipt of the scheduling information by the submitting author. The presenting author must be registered as a PepCon-2015 participant for final scheduling and publication of the abstract.


7. Accepted abstracts will be published in the Congress Proceedings. The authors of the submitted abstracts will take responsibility for any Intellectual Property issues concerning the abstracts on their own. The organizing committee of PepCon-2015 reserves the right to use the submitted abstracts for conference purposes.

China Local Time
 
Days To Go!
Nobel Across China

The "Nobel Across China Program" aims to encourage young scientists to learn the frontier knowledge and strengthen the scientific information exchange, to generate impact on basic research in life science between China and the rest of the world.

Hosting Organizations

China Council for the Promotion of International Trade

Nanjing Municipal Government

Supporting Organization

Information Research Center of International Talents, SAFEA

Operating Organizations
Economic Information Department,
China Council for the Promotion of International Trade

Nanjing Economic and Information Commission

The Bureau of the Nanjing Food and Drug Administration

Nanjing Municipal Investment Promotion Commission

Nanjing Municipal Health Bureau

China Council for the Promotion of International Trade, Nanjing Sub-Council



Zhen-Ao Group

BIT Group Global

Official Travel Agency

BIT World Travel Service, Inc.

Overseas Cooperate
Medias and Journals
Past Renowned Speakers

http://www.bitlifesciences.com/pepcon2014/images/psp/image009.jpg

Dr. Ferenc Hudecz,
Member of the Hungarian Academy of Sciences; Professor, Eotvos Lorand University, Hungary

http://www.bitlifesciences.com/pepcon2014/images/psp/image016.jpg

Dr. Alexander Archakov,
Full member of the Russian Academy of Medical Sciences (RAMS); Professor, Institute of Biomedical Chemistry of Russian Academy of Medical Sciences, Russia

http://www.bitlifesciences.com/pepcon2014/images/psp/image005.jpg

Dr. Lawrence J Berliner,
Fellow of the prestigious American Academy of Arts and Sciences; Professor, Chair, University of Denver, USA

http://www.bitlifesciences.com/uploadfile/2014021809004173499.bmp

Dr. Yanping Yang,
Director, Sanofi Pasteur Canada Limited, Canada

http://www.bitlifesciences.com/pepcon2014/images/psp/jz.jpg

Dr. Jiandi Zhang,
Founder, Zestern Biotechnique LLC., USA

http://www.bitlifesciences.com/uploadfile/2014022814582173499.bmp

Dr. Stefan Kubick,
Head, Fraunhofer Institute for Biomedical Engineering(IBMT), Germany

http://www.bitlifesciences.com/uploadfile/2014011511383173499.jpg

Dr. Lian Li,
Professor and Vice Chair, Department of Pharmacology, Emory University, USA

http://www.bitlifesciences.com/pepcon2014/images/psp/hc.jpg

Dr. Huailing Zhong,
President, U-Pharm Laboratories LLC, USA

http://www.bitlifesciences.com/uploadfile/2013122311185473499.bmp

Dr. Albrecht Groener,
Head Pathogen Safety, CSL Behring, Germany

http://www.bitlifesciences.com/uploadfile/2014021116474173499.bmp

Dr. Nan-Shan Chang,
Professor, Director, National Cheng Kung University, Taiwan

http://www.bitlifesciences.com/uploadfile/2014021911214573499.bmp

Dr. Christian F.W. Becker, 
Professor, Head, University of Vienna, Austria

http://www.bitlifesciences.com/pepcon2014/images/psp/sr.jpg

Dr. Suraiya Rasheed,
Professor, Director, University of Southern California, USA

http://www.bitlifesciences.com/uploadfile/2014011009572473499.jpg

Dr. Jason Z. Huang,
Senior Research Investigator II, Bristol-Myers Squibb Company, USA

http://www.bitlifesciences.com/uploadfile/2014021015080673499.bmp

Dr. Yeu Su,
Professor, National Yang-Ming University, Taiwan

http://www.bitlifesciences.com/pepcon2014/images/psp/shl.jpg

Dr. Sang Hee Lee,
Director, Professor, Myongji University, South Korea

http://www.bitlifesciences.com/uploadfile/2014010309490173499.bmp

Dr. Francesco Mallamace,
Professor, Messina University, Italy

http://www.bitlifesciences.com/uploadfile/2014030708492273499.bmp

Dr. Dvorah Graeser,
CEO, Graeser Associates International Inc., USA

http://www.bitlifesciences.com/uploadfile/2014022111525273499.bmp

Dr. Fengqiao Li,
Vice President, Cognosci, Inc., USA

http://www.bitlifesciences.com/uploadfile/2013121915043573499.jpg

Dr. Miriam Eisenstein,
Head, Weizmann Institute of Science, Israel

http://www.bitlifesciences.com/uploadfile/2014011011294473499.bmp

Dr. Vsevolod J. Makeev,
Head, Vavilov Institute of Genera Genetics Russian Academy of Sciences, Russia

http://www.bitlifesciences.com/uploadfile/2013122715393973499.jpg

Dr. David Witte,  
NanoTemper Technologies GmbH, Germany

http://www.bitlifesciences.com/uploadfile/2014032810374673499.bmp

Dr. Barbara McIntosh,
VP Sales & Marketing, BioDot Inc., USA

http://www.bitlifesciences.com/uploadfile/2014030708543373499.bmp

Dr. Alex I. Smirnov,
Professor, North Carolina State University, Raleigh, USA

http://www.bitlifesciences.com/pepcon2014/images/psp/mh.jpg

Dr. Matthew He,
Director, Full Professor, Nova Southeastern University, USA

http://www.bitlifesciences.com/uploadfile/2014021209364073499.jpg

Dr. Wolfgang Rapp,
CEO, Rapp Polymere GmbH, Germany

http://www.bitlifesciences.com/pepcon2014/images/psp/sd.jpg

Dr. Sebastian Brauchi,
Principal Investigator, Director, The University of Chile, Chile

http://www.bitlifesciences.com/uploadfile/2014030308535073499.bmp

Dr. Dinesh Patel,
President, CEO, Protagonist Therapeutics. Inc, USA

http://www.bitlifesciences.com/pepcon2014/images/psp/dda.jpg

Dr. David Aitken,
Deputy Director, Paris Sud University, France

http://www.bitlifesciences.com/uploadfile/2014022609552773499.jpg

Dr. Jaw-Kang Chang,
President, Phoenix Pharmaceuticals, Inc., USA

http://www.bitlifesciences.com/pepcon2014/images/psp/das.jpg

Dr. Alberto Saiani,
Reader, The University of Manchester, UK

http://www.bitlifesciences.com/uploadfile/2014031208575173499.bmp

Dr. Aline F. Miller,
Reader, The University of Manchester, UK

http://www.bitlifesciences.com/uploadfile/2014022715083773499.bmp

Dr. Kazunori Matsuura,
Professor, Totttori University, Japan

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.